Follow
Stéphane Supiot
Stéphane Supiot
University of Nantes
Verified email at ico.unicancer.fr
Title
Cited by
Cited by
Year
Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer
CN Catton, H Lukka, CS Gu, JM Martin, S Supiot, PWM Chung, ...
Journal of Clinical Oncology 35 (17), 1884-1890, 2017
6432017
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised …
C Carrie, A Hasbini, G de Laroche, P Richaud, S Guerif, I Latorzeff, ...
The Lancet Oncology 17 (6), 747-756, 2016
3902016
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label …
K Fizazi, S Foulon, J Carles, G Roubaud, R McDermott, A Fléchon, ...
The Lancet 399 (10336), 1695-1707, 2022
3702022
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG …
P Sargos, S Chabaud, I Latorzeff, N Magné, A Benyoucef, S Supiot, ...
The Lancet Oncology 21 (10), 1341-1352, 2020
2252020
Cancer radioimmunotherapy with alpha-emitting nuclides
O Couturier, S Supiot, M Degraef-Mougin, A Faivre-Chauvet, T Carlier, ...
European journal of nuclear medicine and molecular imaging 32, 601-614, 2005
2202005
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of …
C Carrie, N Magné, P Burban-Provost, P Sargos, I Latorzeff, JL Lagrange, ...
The Lancet Oncology 20 (12), 1740-1749, 2019
1842019
Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity
A Choudhury, H Zhao, F Jalali, S Al Rashid, J Ran, S Supiot, AE Kiltie, ...
Molecular cancer therapeutics 8 (1), 203-213, 2009
1222009
Daily versus weekly prostate cancer image guided radiation therapy: phase 3 multicenter randomized trial
R de Crevoisier, MA Bayar, P Pommier, X Muracciole, F Pêne, P Dudouet, ...
International Journal of Radiation Oncology* Biology* Physics 102 (5), 1420-1429, 2018
1082018
A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity
N Alvarez-Rueda, A Desselle, D Cochonneau, T Chaumette, ...
PloS one 6 (9), e25220, 2011
1042011
Comparison of automated atlas-based segmentation software for postoperative prostate cancer radiotherapy
G Delpon, A Escande, T Ruef, J Darréon, J Fontaine, C Noblet, S Supiot, ...
Frontiers in oncology 6, 178, 2016
912016
The importance of the vascular endothelial barrier in the immune-inflammatory response induced by radiotherapy
O Guipaud, C Jaillet, K Clément-Colmou, A François, S Supiot, F Milliat
The British journal of radiology 91 (1089), 20170762, 2018
842018
Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53
S Supiot, RP Hill, RG Bristow
Molecular cancer therapeutics 7 (4), 993-999, 2008
842008
Interstitial brachytherapy of periorificial skin carcinomas of the face: a retrospective study of 97 cases
E Rio, E Bardet, C Ferron, P Peuvrel, S Supiot, L Campion, ...
International Journal of Radiation Oncology* Biology* physics 63 (3), 753-757, 2005
812005
Improved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer
VA Potiron, R Abderrahmani, K Clément-Colmou, S Marionneau-Lambot, ...
PloS one 8 (12), e84076, 2013
802013
LBA5 A phase III trial with a 2x2 factorial design in men with de novo metastatic castration-sensitive prostate cancer: overall survival with abiraterone acetate plus …
K Fizazi, JC Galceran, S Foulon, G Roubaud, R McDermott, A Fléchon, ...
Annals of Oncology 32, S1299, 2021
782021
Videotaped simulated interviews to improve medical students' skills in disclosing a diagnosis of cancer
A Bonnaud‐Antignac, L Campion, P Pottier, S Supiot
Psycho‐Oncology 19 (9), 975-981, 2010
702010
Comparison of the biologic effects of MA5 and B‐B4 monoclonal antibody labeled with iodine‐131 and bismuth‐213 on multiple myeloma
S Supiot, A Faivre‐Chauvet, O Couturier, MF Heymann, N Robillard, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2002
702002
Mechanisms of cell sensitization to α radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines
S Supiot, S Gouard, J Charrier, C Apostolidis, JF Chatal, J Barbet, ...
Clinical cancer research 11 (19), 7047s-7052s, 2005
672005
Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions
VA Potiron, R Abderrhamani, E Giang, S Chiavassa, E Di Tomaso, ...
Radiotherapy and Oncology 106 (1), 138-146, 2013
622013
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours
C Lévy, D Allouache, J Lacroix, AE Dugue, S Supiot, M Campone, ...
Annals of oncology 25 (12), 2351-2356, 2014
602014
The system can't perform the operation now. Try again later.
Articles 1–20